Skip to content

The safety and efficacy of adjuvant liver suspension technique in patients with complex liver segments undergoing laparoscopic hepatectomy­­--a prospective, randomized controlled study.

The safety and efficacy of adjuvant liver suspension technique in patients with complex liver segments undergoing laparoscopic hepatectomy­­--a prospective, randomized controlled study.

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075994
Enrollment
Unknown
Registered
2023-09-21
Start date
2023-10-01
Completion date
Unknown
Last updated
2023-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver cancer

Interventions

Liver suspension device (the experimental group):A laparoscopic hepatectomy simple suspension device is inserted through the Trocar hole. After the needle holder adjusts the needle, the target liver
laparoscopic hepatectomy alone (the control group):Routine laparoscopic hepatectomy

Sponsors

Third Affiliated Hospital of Naval Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Be between 18 and 75 years old, regardless of gender; 2) The case data is complete, and the diagnosis is hepatocellular carcinoma (AFP, DCP increase with CT, MRI for diagnosis) 3) The tumor is located in the S1, S4a, S7, S8 segments, and laparoscopic surgery is planned 4) Patients whose tumors are BCLC staged (Barcelona stage) for stage 0-A 5) Preoperative liver function score of Child-pough stage A 6) Good preoperative cardiopulmonary function assessment and able to tolerate surgery 7) Those who can understand the situation of this research and have signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1) Patients who need to open the abdomen due to other surgical procedures 2) Patients who have multiple surgeries and need to spend a lot of time to release abdominal or intestinal adhesions 3) Patients with intraoperative blood loss or abdominal opening caused by non-complicated liver segment resection factors 4) Patients who are forced to undergo emergency surgery due to tumor rupture and bleeding 5) Mental abnormalities 6) Coagulation dysfunction 7) Patients who cannot obtain informed consent.

Design outcomes

Primary

MeasureTime frame
Amount of intraoperative bleeding;Intraoperative transfusion rate;Duration of surgery;

Secondary

MeasureTime frame
Postoperative biliary leakage incidence;Surgeon satisfaction;

Countries

China

Contacts

Public ContactXiaoying Zhu

Third Affiliated Hospital of Naval Medical University

weixingg88@126.com+86 138 1628 5166

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 19, 2026